Capital Grand Est

Sirfull is a software company based in Schiltigheim, France, that specializes in developing cloud-based solutions for welding quality and equipment life cycle management. The company offers VDB, a welding quality management software designed to oversee welding quality control and technical documentation, and IRM, an equipment inspection software that facilitates the inspection, monitoring, and risk management of industrial equipment. These solutions help centralize processes on a collaborative platform, thereby enhancing operational efficiency and reducing maintenance costs for clients in various sectors, including oil and gas, nuclear energy, and pharmaceuticals. Additionally, Sirfull provides technical outsourcing and integration services, with its software available as a Software-as-a-Service or for PC/server installation. The company has sales offices in Strasbourg and Lyon, serving manufacturers and operating companies looking to optimize their business processes through digital manufacturing.

Exeliom is a clinical-stage biopharmaceutical company based in Dijon, France, focused on developing innovative microbial therapies that utilize commensal bacteria as therapeutic agents. Founded in 2016, Exeliom aims to unlock the therapeutic potential of gut microbiota to enhance health and longevity. The company specializes in creating a new class of medicines known as Live Biotherapeutics, which are designed to deliver microbiome-based immunotherapy for conditions such as inflammatory bowel diseases and cancer, with an initial focus on Crohn's Disease. By harnessing the role of microbiota in the immune system, Exeliom strives to provide patients with advanced treatments that improve their quality of life.

Braintale is a Paris-based company founded in 2018 that develops and distributes diagnostic and prognostic tools specifically designed for brain-injured patients. Its platform focuses on analyzing MRI reports to assist healthcare professionals in effectively diagnosing patients who are in comas due to severe traumatic brain injuries, cardiac arrests, or hemorrhagic strokes. With over 15 years of clinical development backing its products, Braintale aims to meet the expectations of both healthcare professionals and patients by providing accessible and effective tools for prognosis and diagnosis in critical care settings.